MicroRNA-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target

Journal of Cardiovascular Pharmacology

Volumn 62, Issue 3, 2013, Pages 312-319

  Zhang, Zhen Hui ^a   Li, Jiao ^a   Liu, Ben Rong ^b   Luo, Cheng Feng ^a   Dong, Qi ^a   Zhao, Lu Ning ^a   Zhong, Yun ^b   Chen, Wei Yan ^a   Chen, Min Sheng ^b   Liu, Shi Ming ^a,b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b Guangzhou Institute of Cardiovascular Disease   (China)

Author keywords

Cardiac hypertrophy; Glycogen synthase kinase 3 ; MicroRNA 26

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MICRORNA; MICRORNA 26; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT;

ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENETIC THERAPY; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HUMANS; MALE; MICRORNAS; MOLECULAR TARGETED THERAPY; MYOCARDIUM; MYOCYTES, CARDIAC; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; UP-REGULATION;

EID: 84884671476     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31829b82e6     Document Type: Article

References (30)

1. Toischer K, Rokita AG, Unsold B, et al. Differential cardiac remodeling in preload versus afterload. Circulation. 2010;122:993-1003
2. Shah AM, Hung CL, Shin SH, et al. Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both. Am Heart J. 2011;162:685-691
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843-854
4. Filipowicz W, Bhattacharvva SN, Sonenberg N. Mechanisms of posttranscriptional regulation by microRNAs: Are the answers in sight? Nat Rev Genet. 2008;9:102-114
5. Zhang J, Zhang T, Ti X, et al. Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an micro- RNA signaling pathway. Biochem Biophys Res Commun. 2010;399:1-6
6. Zhang J, Zhang T, Ti X, et al. Dysregulation of cardiogenesis, cardiac conduction and cell cycle in mice lacking microRNA-1-2. Cell. 2007; 129:303-317
7. Haghikia A, Hilfiker-Kleiner D. MicroRNA-21: A key to controlling the cardiac fibroblast compartment? Cardiovasc Res. 2009;82:1-3
8. Katare R, Riu F, Mitchell K, et al. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res. 2011;109:894-906
9. Ikeda S, He A, Kong SW, et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol. 2009;29:2193-2204
10. Thum T, Galuppo P, Wolf C, et al. MicroRNAs in the human heart: A clue to fetal gene reprogramming in heart failure. Circulation. 2007;116:258-267
11. Zhang B, Liu XX, He JR, et al. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis. 2010;32:2-9
12. Maillot G, Lacroix-Triki M, Pierredon S, et al. Widespread estrogendependent repression of microRNAs in breast tumor cell growth. Cancer Res. 2009;69:8332-8340
13. Ikeda S, Kong SW, Lu J, et al. Altered microRNA expression in human heart disease. Physiol Genomics. 2007;31:367-373
14. Han JJ, Hao J, Kim CH, et al. Quercetin prevents cardiac hypertrophy induced by pressure overload in rats. J Vet Med Sci. 2009;71:734-743
15. Woodcock EA, Wang BH, Arthur JF, et al. Inositol polyphosphate 1-phosphatase is a novel antihypertrophic factor. J Biol Chem. 2002; 277:22734-22742
16. Custodis F, Eberl M, Kilter H, et al. Laufs. Association of RhoGDIalphha with Rac1 GTPase mediates free radical production during myocardial hypertrophy. Cardiovasc Res. 2006;71:342-351
17. Li H, Telemaque S, Miller RE, et al. High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl. Diabetes. 2005;54:540-545
18. Lundstrom K. Micro-RNA in disease and gene therapy. Curr Drug Discov Technol. 2011;8:76-86
19. Sayed D, Hong C, Chen IY, et al. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res. 2007;100:416-424
20. Février B, Raposo G. Exosomes: Endosomal-derived vesicles shipping extracullular messages. Curr Opin Cell Biol. 2004;16:415-421
21. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 2011;108:5003-5008
22. Mohamed JS, Lopez MA, Boriek AM. Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3beta. J Biol Chem. 2010;285: 29336-29347
23. Hardt SE, Sadoshima J. Glycogen synthase kinase-3beta: A novel regulator of cardiac hypertrophy and development. Circ Res. 2002;90: 1055-1063
24. Michael A, Haq S, Chen X, et al. Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart. J Biol Chem. 2004;279:21383-21393
25. Juhaszova M, Zorov DB, Yaniv Y, et al. Role of glycogen synthase kinase-3beta in cardioprotection. Circ Res. 2009;104:1240-1252
26. Haq S, Choukroun G, Kang ZB, et al. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol. 2000; 151:117-130
27. Badorff C, Seeger FH, Zeiher AM, et al. Glycogen synthase kinase 3beta inhibits myocardin-dependent transcription and hypertrophy induction through site-specific phosphorylation. Circ Res. 2005;97:645-654
28. Antos CL, McKinsey TA, Frey N, et al. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A 2002;99:907-912
29. Tong H, Imahashi K, Steenbergen C, et al. Phosphorylation of glycogen synthase kinase-3 beta during preconditioning through a phosphatidylinositol- 3-kinase - dependent pathway is cardioprotective. Circ Res. 2002;90: 377-379
30. Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol. 2001;65:391-426